AUB ScholarWorks

Diode laser transcleral cyclophotocoagulation for refractory glaucoma: A 1 year follow-up of patients treated using an aggressive protocol

Show simple item record

dc.contributor.author Noureddin B.N.
dc.contributor.author Zein W.
dc.contributor.author Haddad C.
dc.contributor.author Ma'luf R.
dc.contributor.author Bashshur Z.
dc.contributor.editor
dc.date Mar-2006
dc.date.accessioned 2017-10-05T15:49:16Z
dc.date.available 2017-10-05T15:49:16Z
dc.date.issued 2006
dc.identifier 10.1038/sj.eye.6701875
dc.identifier.isbn
dc.identifier.issn
dc.identifier.uri http://hdl.handle.net/10938/18743
dc.description.abstract Purpose: To prospectively evaluate the intraocular pressure (IOP) lowering ability, retreatment rate, and complications of transcleral Diode laser cyclophotocoagulation using a higher power setting than what is generally recommended. Patients and methods: A total of 36 eyes of thirty six patients with refractory glaucoma, and who fitted our inclusion criteria underwent Diode cyclophotocoagulation. The laser power was set at 2250 mW, with a duration of 2000 ms, and a total number of 28 shots for the first treatment and 20 shots for any consequent one. The patients were followed up for 1 year with the following outcomes being analysed: IOP, visual acuity, change in the number of medications, and complications. Results: The mean IOP decrease was 53percent (P0.05), and 72.2percent of the patients maintained an IOP ≤21 mmHg for the whole duration of the study The number of medications necessary to control the pressure, significantly dropped from 2.8 to 0.89 (P0.05), and 25percent of the patients needed the treatment to be repeated only once.In all, 33percent of the patients improved their visual acuity after the treatment, while 22percent worsened, and the rest stayed the same. The most common treatment complications were conjunctival injection and corneal oedema, and these were both transient and reversible. Conclusion: The use of the higher power setting of 2250 mW, resulted in a sustained lower IOP, less use of medications, less need for retreatment, relative preservation of visual acuity, and only reversible complications. © 2006 Nature Publishing Group. All rights reserved.
dc.format.extent
dc.format.extent Pages: (329-335)
dc.language English
dc.publisher LONDON
dc.relation.ispartof Publication Name: Eye; Publication Year: 2006; Volume: 20; no. 3; Pages: (329-335);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Diode laser transcleral cyclophotocoagulation for refractory glaucoma: A 1 year follow-up of patients treated using an aggressive protocol
dc.type Article
dc.contributor.affiliation Noureddin, B.N., Department of Ophthalmology, American University of Beirut, Bliss Street, Beirut, Lebanon
dc.contributor.affiliation Zein, W., Department of Ophthalmology, American University of Beirut, Bliss Street, Beirut, Lebanon
dc.contributor.affiliation Haddad, C., Department of Ophthalmology, American University of Beirut, Bliss Street, Beirut, Lebanon
dc.contributor.affiliation Ma'luf, R., Department of Ophthalmology, American University of Beirut, Bliss Street, Beirut, Lebanon
dc.contributor.affiliation Bashshur, Z., Department of Ophthalmology, American University of Beirut, Bliss Street, Beirut, Lebanon
dc.contributor.authorAddress Noureddin, B.N.; Department of Ophthalmology, American University of Beirut, Bliss Street, Beirut, Lebanon; email: bndean@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Ophthalmology;
dc.contributor.authorDepartment Ophthalmology
dc.contributor.authorDivision
dc.contributor.authorEmail bndean@aub.edu.lb
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Noureddin, BN
dc.contributor.authorInitials Zein, W
dc.contributor.authorInitials Haddad, C
dc.contributor.authorInitials Ma'luf, R
dc.contributor.authorInitials Bashshur, Z
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Noureddin, BN (reprint author), Amer Univ Beirut, Dept Ophthalmol, POB 11-0236,Bliss St, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Bloom PA, 1997, OPHTHALMOLOGY, V104, P1508; Brancato R, 1995, Eur J Ophthalmol, V5, P32; Chang SHL, 2004, CAN J OPHTHALMOL, V39, P511; Gupta N, 1997, J GLAUCOMA, V6, P426; Hauber FA, 2002, J GLAUCOMA, V11, P329, DOI 10.1097-01.IJG.0000021460.34376.B0; HAWKINS TA, 1993, ARCH OPHTHALMOL-CHIC, V111, P488; HENNIS HL, 1992, AM J OPHTHALMOL, V113, P81; Izgi B, 2001, OPHTHALMIC SURG LAS, V32, P100; Kosoko O, 1996, OPHTHALMOLOGY, V103, P1294; Kramp K, 2002, GRAEF ARCH CLIN EXP, V240, P698, DOI 10.1007-s00417-002-0508-5; Lai JSM, 2003, J GLAUCOMA, V12, P360, DOI 10.1097-00061198-200308000-00011; McKelvie PA, 2002, BRIT J OPHTHALMOL, V86, P381, DOI 10.1136-bjo.86.4.381; Mistlberger A, 2001, J GLAUCOMA, V10, P288, DOI 10.1097-00061198-200108000-00008; NOUREDDIN BN, 1992, OPHTHALMOLOGY, V99, P430; Pastor SA, 2001, OPHTHALMOLOGY, V108, P2130, DOI 10.1016-S0161-6420(01)00889-2; Rebolleda G, 1999, J GLAUCOMA, V8, P177; Schlote T, 2001, J Glaucoma, V10, P294, DOI 10.1097-00061198-200108000-00009; SCHUMAN JS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1534; Sengupta R, 2000, EYE, V14, P808; Walland MJ, 1998, OPHTHALMIC SURG LAS, V29, P852; Wong EYM, 1997, AM J OPHTHALMOL, V124, P797; Yap-Veloso MIR, 1998, J GLAUCOMA, V7, P319
dc.description.citedCount 15
dc.description.citedTotWOSCount 16
dc.description.citedWOSCount 14
dc.format.extentCount 7
dc.identifier.articleNo
dc.identifier.coden EYEEE
dc.identifier.pubmedID 15877101
dc.identifier.scopusID 33646246976
dc.identifier.url
dc.publisher.address MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Eye
dc.relation.ispartOfIssue 3
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Eye
dc.relation.ispartofPubTitleAbbr Eye
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 20
dc.source.ID WOS:000235730200011
dc.type.publication Journal
dc.subject.otherAuthKeyword Diode cyclophotocoagulation
dc.subject.otherAuthKeyword Glaucoma
dc.subject.otherAuthKeyword Intractable glaucoma
dc.subject.otherAuthKeyword Intraocular pressure
dc.subject.otherChemCAS brimonidine, 59803-98-4
dc.subject.otherChemCAS prednisolone acetate, 52-21-1, 52628-64-5
dc.subject.otherChemCAS Antihypertensive Agents
dc.subject.otherIndex antiglaucoma agent
dc.subject.otherIndex beta adrenergic receptor blocking agent
dc.subject.otherIndex brimonidine
dc.subject.otherIndex carbonate dehydratase inhibitor
dc.subject.otherIndex dorzolamide plus timolol
dc.subject.otherIndex miotic agent
dc.subject.otherIndex prednisolone acetate
dc.subject.otherIndex prostaglandin
dc.subject.otherIndex adolescent
dc.subject.otherIndex adult
dc.subject.otherIndex aged
dc.subject.otherIndex anterior eye chamber
dc.subject.otherIndex article
dc.subject.otherIndex child
dc.subject.otherIndex clinical article
dc.subject.otherIndex clinical protocol
dc.subject.otherIndex clinical trial
dc.subject.otherIndex conjunctiva disease
dc.subject.otherIndex controlled clinical trial
dc.subject.otherIndex controlled study
dc.subject.otherIndex cornea edema
dc.subject.otherIndex diode laser
dc.subject.otherIndex disease exacerbation
dc.subject.otherIndex drug use
dc.subject.otherIndex female
dc.subject.otherIndex follow up
dc.subject.otherIndex glaucoma
dc.subject.otherIndex human
dc.subject.otherIndex hyphema
dc.subject.otherIndex hypopyon
dc.subject.otherIndex intraocular hypotension
dc.subject.otherIndex intraocular pressure
dc.subject.otherIndex laser coagulation
dc.subject.otherIndex male
dc.subject.otherIndex outcomes research
dc.subject.otherIndex pressure measurement
dc.subject.otherIndex prospective study
dc.subject.otherIndex visual acuity
dc.subject.otherIndex vitreous hemorrhage
dc.subject.otherIndex Adolescent
dc.subject.otherIndex Adult
dc.subject.otherIndex Aged
dc.subject.otherIndex Aged, 80 and over
dc.subject.otherIndex Antihypertensive Agents
dc.subject.otherIndex Child
dc.subject.otherIndex Drug Administration Schedule
dc.subject.otherIndex Female
dc.subject.otherIndex Follow-Up Studies
dc.subject.otherIndex Glaucoma
dc.subject.otherIndex Humans
dc.subject.otherIndex Intraocular Pressure
dc.subject.otherIndex Laser Coagulation
dc.subject.otherIndex Male
dc.subject.otherIndex Middle Aged
dc.subject.otherIndex Prospective Studies
dc.subject.otherIndex Reoperation
dc.subject.otherIndex Treatment Outcome
dc.subject.otherIndex Visual Acuity
dc.subject.otherKeywordPlus TRANSSCLERAL CYCLOPHOTOCOAGULATION
dc.subject.otherKeywordPlus CYCLODIODE
dc.subject.otherKeywordPlus EYES
dc.subject.otherKeywordPlus SURGERY
dc.subject.otherWOS Ophthalmology


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account